gosogliptin

Gosogliptin is a potent, orally active, highly selective and competitive inhibitor of DPP-4 (dipeptidyl peptidase 4), increasing the levels of intestinal glucagon peptide (GLP-1) and glucose-dependent proinsulinotropic polypeptide (GIP), thereby enhancing insulin secretion and lowering blood glucose levels. In animal studies, Gosogliptin rapidly, orally and reversibly inhibits plasma DPP-4 activity.

Gosogliptin hydrochloride is the hydrochloride salt of Gosogliptin. Gosogliptin (PF-00734200) is a potent, orally active selective competitive inhibitor of DPP-IV, which is primarily responsible for degrading the incretin hormones GLP-1 and glucose-dependent insulinotropic polypeptide. Gosogliptin rapidly and reversibly inhibits plasma DPP-4 activity, stimulates insulin secretion, and improves glucose tolerance.